NEUGEBOREN EDWARD 4
4 · Grace Therapeutics, Inc. · Filed Jan 12, 2026
Insider Transaction Report
Form 4
NEUGEBOREN EDWARD
Director
Transactions
- Award
Stock Option (Right to Buy)
[F1]2026-01-08+10,000→ 10,000 totalExercise: $3.80Exp: 2036-01-08→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]25% of this option vests on the date of grant and the remaining 75% vests in substantially equal monthly installments on the 30th day of each month until September 30, 2026, subject to the Reporting Person's continuous service as of each vesting date.
Signature
/s/ Robert DelAversano as attorney-in-fact for Edward Neugeboren|2026-01-12